FDA Watch: Agency Takes Steps to Downgrade Some Nucleic Acid-Based Tests to Class II
The change is expected to dramatically cut the costs of developing new tests
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
The change is expected to dramatically cut the costs of developing new tests
CMS tweaked its CE, documentation, and on-site visit requirements for directors
With new modifications to HIPAA potentially on the horizon, we hear from experts on HHS' proposal
The Syn-One assay can diagnose multiple conditions without needing a lumbar puncture
By not modernizing legacy systems and software, labs risk incurring hidden costs
The technology developed by Roche in recent years seems a good fit for Labcorp’s testing services
Third-party verification of lab personnel experience is now a CLIA requirement
Bill that ended government shutdown includes provision to hold off PAMA cuts
How clinical laboratories should prepare for the next wave of oversight in the new year
How laboratory staff can steer clear of common mistakes when handling and storing chemical waste
Australian firm has grown its overseas operations dramatically in the past decade, except in America